Web information on Motavizumab
Relevant Clinical Literature
Please read pharmacological data limitations
Wikipedia on Motavizumab (Less technical, ? quality control)
Development of motavizumab, a monoclonal antibody that bound to a conserved neutralizing epitope on the RSV F protein and was thought to prevent essential steps of the infection process was discontinued in 2010. It was similar to palivizumab.